NUKLEINSÄURE-ENZYMSUBSTRATE

European patent · EP2753717 · In force

Register entry

Publication number
EP2753717
Application number
EP12830774
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 10, 2012
Published
Jul 16, 2014
Granted
Oct 31, 2018
Protection ends at the latest
Sep 9, 2032
Next annual fee due
Sep 30, 2027
IPC classes
C12Q 1/6823 (2018.01)
C12Q 1/686 (2018.01)
C12Q 1/6865 (2018.01)
C12Q 1/6818 (2018.01)
Priority
AU 2011903686 09.09.2011
PCT application
PCT/AU2012/001081 10.09.2012
PCT publication
WO2013/033792 14.03.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. Oct 3, 2024

    Change

    Published in Swissreg on 03.10.2024

  4. Oct 1, 2023

    Change

    Published in Swissreg on 01.10.2023

  5. Oct 1, 2022

    Change

    Published in Swissreg on 01.10.2022

  6. Nov 6, 2018

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 06.11.2018

  7. Oct 31, 2018

    Granted

    Published in Swissreg on 31.10.2018

Parties

Inventor

LONERGAN, Dina

Coogee, NSW 2034, AU

TODD, Alison Velyian

Glebe, NSW 2037, AU

LINARDY, Evelyn Meiria

Woodcroft, NSW 2767, AU

MOKANY, Elisa

Caringbah, NSW 2229, AU

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.